E-LIB Suche - Ergebnisse für: Rasco, B. C.

1

Proton Shell Gaps in N=28 Nuclei from the First Complete Sp..:

Cox, I. ; Xu, Z. Y. ; Grzywacz, R....
Physical Review Letters. 132 (2024) 15 - p. , 2024

Link: https://doi.org/10.1103/..

2

A first-in-human phase I study of the PD-1 inhibitor, retif..:

Lakhani, N. ; Cosman, R. ; Banerji, U....
ESMO Open. 9 (2024) 4 - p. 102254 , 2024

Link: https://doi.org/10.1016/..

3

Absolute Branching Ratios of Prominent γ Rays Following α D..:

Gray, T.J. ; Allmond, J.M. ; Evans, L.G....
Nuclear Data Sheets. 193 (2024) - p. 88-94 , 2024

Link: https://doi.org/10.1016/..

4

Precision measurement of 65Zn electron-capture decays with ..:

Hariasz, L. ; Di Stefano, P.C.F. ; Stukel, M....
Nuclear Data Sheets. 189 (2023) - p. 224-234 , 2023

Link: https://doi.org/10.1016/..

5

Improving fission-product decay data for reactor applicatio..:

Nichols, A. L. ; Dimitriou, P. ; Algora, A....
The European Physical Journal A. 59 (2023) 4 - p. , 2023

Link: https://doi.org/10.1140/..

6

Rare K40 Decay with Implications for Fundamental Physics an..:

Stukel, M. ; Hariasz, L. ; Di Stefano, P. C. F....
Physical Review Letters. 131 (2023) 5 - p. , 2023

Link: https://doi.org/10.1103/..

7

Phase 1 study of the pan-RAF inhibitor tovorafenib in patie..:

Rasco, Drew W. ; Medina, Theresa ; Corrie, Pippa...
Cancer Chemotherapy and Pharmacology. 92 (2023) 1 - p. 15-28 , 2023

Link: https://doi.org/10.1007/..

8

128P A phase I dose escalation and expansion trial of LYT-2..:

Falchook, G. ; Rasco, D. ; Papadopoulos, K....
Immuno-Oncology and Technology. 20 (2023) - p. 100600 , 2023

Link: https://doi.org/10.1016/..

9

Pharmacokinetics and immunogenicity of eftozanermin alfa in..:

Biesdorf, Carla ; Guan, Xiaowen ; Siddani, Satya R....
Cancer Chemotherapy and Pharmacology. , 2023

Link: https://doi.org/10.1007/..

10

158P Triple blockade of the DNAM-axis with COM701 + BMS-986..:

Moroney, J. ; Yeku, O. ; Fleming, G....
Immuno-Oncology and Technology. 16 (2022) - p. 100270 , 2022

Link: https://doi.org/10.1016/..

11

Eftozanermin alfa (ABBV-621) monotherapy in patients with p..:

LoRusso, Patricia ; Ratain, Mark J. ; Doi, Toshihiko...
Investigational New Drugs. 40 (2022) 4 - p. 762-772 , 2022

Link: https://doi.org/10.1007/..

12

Phase I Study of Glesatinib (MGCD265) in Combination with E..:

Patnaik, Amita ; Gadgeel, Shirish ; Papadopoulos, Kyriakos P....
Targeted Oncology. 17 (2022) 2 - p. 125-138 , 2022

Link: https://doi.org/10.1007/..

13

130P COM701 ± nivolumab: Preliminary results of antitumor a..:

Sullivan, R.J. ; Sharma, M.R. ; Vaena, D....
Immuno-Oncology and Technology. 16 (2022) - p. 100242 , 2022

Link: https://doi.org/10.1016/..

14

Correction to: Phase I Study of Glesatinib (MGCD265) in Com..:

Patnaik, Amita ; Gadgeel, Shirish ; Papadopoulos, Kyriakos P....
Targeted Oncology. 17 (2022) 2 - p. 139-139 , 2022

Link: https://doi.org/10.1007/..

15

First-in-human phase 1 study of the anti-TIGIT antibody vib..:

Niu, J. ; Maurice-Dror, C. ; Lee, D.H....
Annals of Oncology. 33 (2022) 2 - p. 169-180 , 2022

Link: https://doi.org/10.1016/..